Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
News Releases

Fasken Martineau advises Concordia Healthcare on its US$3.5 billion acquisition of Amdipharm Mercury Limited

Fasken
Reading Time 2 minute read Subscribe
Fasken Martineau announced today that it acted as Canadian counsel to Concordia Healthcare Corp. (“Concordia”) in connection with its agreement to acquire UK-based Amdipharm Mercury Limited (“AMCo”). The deal is valued at US$3.5 billion which will be paid for by Concordia through a combination of cash and shares of Concordia, together with a performance-based earn-out payable in cash.

Toronto (Canada) - Fasken Martineau, a leading international business law and litigation firm, announced today that it acted as Canadian counsel to Concordia Healthcare Corp. (“Concordia”) in connection with its agreement to acquire UK-based Amdipharm Mercury Limited (“AMCo”). The deal is valued at US$3.5 billion which will be paid for by Concordia through a combination of cash and shares of Concordia, together with a performance-based earn-out payable in cash.

Concordia, headquartered in Oakville, Ontario with facilities in Bridgetown, Barbados, Roanoke, Virginia, Chicago, Illinois and Kansas City, Missouri, is a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs.

“In a year that has been characterized by very large pharma deals, we are pleased to be part of the team advising our client Concordia on their acquisition of Amdipharm Mercury and moving their operation forward to a new level. We look forward to providing counsel to Concordia as they continue their growth strategy,” said lead lawyer Rubin Rapuch, an M&A partner at Fasken Martineau Toronto.

In April 2015 Fasken Martineau acted as Canadian counsel to Concordia on its other major acquisition of the year of a portfolio of products from Covis Pharma. The all-cash deal was valued at US$1.2 billion.

Concordia was advised by a Fasken Martineau team led by M&A partners Rubin Rapuch and John Sabetti and included Jon Holmstrom (banking & finance), Mitchell Thaw (tax), Timothy Squire (intellectual property), and associates Jessica Catton Rinaldi (M&A), Myroslav Chwaluk, Justine Connors and  Noel Chow (corporate/commercial).

Also advising Concordia on the acquisition of AMCo were Sullivan & Cromwell LLP (US and UK) and Simmons & Simmons (UK).

About Fasken Martineau

Fasken Martineau is a leading international business law and litigation firm. With more than 770 lawyers, the firm has offices in Vancouver, Calgary, Toronto, Ottawa, Montréal, Québec City, London, Paris and Johannesburg. For additional information, please visit the firm's website at www.fasken.com.

    Subscribe

    Receive email updates from our team

    Subscribe